Clinical Drug Experience Knowledgebase

EC0.1ml (1 trial)

Mycobacterium vaccae (2 trials)

recombinant sars-cov-2 vaccine (20 trials)

tb-ppd (1 trial)

15-valent pneumococcal conjugate vaccine (VAXNEUVANCE) (3 trials)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

bacille calmette-guerin (5 trials)

Bivalent group A and C meningococcal vaccine (Menomune-A/C) (2 trials)

esat6-cfp10 (6 trials)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (3 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)

rabies vaccine (2 trials)

rabies vaccine, human isolate (1 trial)

recombinant mycobacterium tuberculosis fusion protein (1 trial)

s.flexneriza-s.sonnei bivalent conjugate vaccine (3 trials)

tetravalent influenza virus lysis vaccine (1 trial)

Tuberculin, Purified Protein Derivative (Tubersol) (3 trials)

aec / bc02 (2 trials)

ev71 vaccine (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

menabc (1 trial)

renov gi.1-vp1 (1 trial)

mycobacterium tuberculosis antigen (1 trial)

inactivated covid-19 vaccine (1 trial)

omicron covid-19 vaccine (vero cell), inactivated (1 trial)